MECOM and chronic myelogenous leukemia, BCR-ABL1 positive: To evaluate a leukemogenic function of Evi1-high cells in CML-BC, BCR–ABL and NUP98–HOXA9 were co-transduced37 into 5FU-primed BM of Evi1+/GFP mice to establish Evi1-reporter CML-BC mice (Figure 4a).